Related Experiment Video

Updated: Jul 10, 2026

Subcellular Fractionation for ERK Activation Upon Mitochondrial-derived Peptide Treatment
07:55

Subcellular Fractionation for ERK Activation Upon Mitochondrial-derived Peptide Treatment

Published on: September 25, 2017

Canonical and alternative MAPK signaling

Genaro Pimienta1, Jaime Pascual

  • 1Inflammation and Infectious Diseases Center, Burnham Institute for Medical Research, La Jolla, California 92037, USA.

Cell Cycle (Georgetown, Tex.)
|October 25, 2007
PubMed

Insights

Mitogen-activated protein kinase (MAPK) activation is complex, involving non-canonical pathways and cross-talk. This study proposes a new model for MAPK signal transduction integrating these diverse mechanisms.

Area of Science:

  • Cellular Biology
  • Molecular Biology
  • Biochemistry

Background:

  • The canonical model of mitogen-activated protein kinase (MAPK) cascade activation is being challenged by new findings.
  • Unexpected phosphorylation patterns, alternative activation mechanisms, and altered sub-cellular localization have been observed in MAPK family members.

Purpose of the Study:

  • To summarize the current understanding of MAPK activation pathways, focusing on non-canonical examples.
  • To propose a novel model for MAPK signal transduction that incorporates cross-talk between different MAPK subgroups.

Main Methods:

  • Review and synthesis of recent literature on MAPK activation.
  • Analysis of non-canonical activation mechanisms, including autophosphorylation and dosage compensation.
  • Development of a conceptual model for MAPK signal transduction.

Main Results:

  • Autophosphorylation pathways are confirmed for ERK1/2, JNK1/2, and p38 alpha/beta.
  • Dosage compensation between homologs occurs in ERK1/2 and JNK1/2 signaling.
  • Non-canonical substrate specificity during MAPK auto-activation is linked to homo- and hetero-dimerization.

Conclusions:

  • The traditional view of MAPK activation is insufficient to explain observed complexities.
  • A new model is proposed highlighting cross-talk between MAPKs with distinct motifs and C-terminal extensions.
  • MAPK auto-activation and dimerization play crucial roles in signal transduction specificity.

More Related Videos

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants07:38

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on: June 6, 2025

Imaging Spatial Reorganization of a MAPK Signaling Pathway Using the Tobacco Transient Expression System08:54

Imaging Spatial Reorganization of a MAPK Signaling Pathway Using the Tobacco Transient Expression System

Published on: March 20, 2016

Related Concept Videos

MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
Calmodulin-dependent Signaling01:16

Calmodulin-dependent Signaling

Calmodulin (CaM) is a calcium-binding protein in eukaryotes that controls various calcium-regulated cellular processes. It has four calcium-binding sites that bind calcium to form the calcium-calmodulin ( Ca2+-CaM) complex. GPCR stimulation increases the calcium levels in the cells that bind to CaM and induces a conformational change.
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...